Lifetime marijuana and alcohol use, and cognitive dysfunction in people with human immunodeficiency virus infection

References

• Patel SM, Thames A, Arbid N, Panos S, Castellon S, Hinkin CH. The aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individuals. J Clin Exp Neuropsychol. 2013;35:421–434. doi: 10.1080/13803395.2013.783000.https://doi.org/10.1080/13803395.2013.78300010.1080/13803395.2013.783000 PMID: 23547924
   PubMed Web of Science ®Google Scholar
• Fogarty A, Rawstorne P, Prestage G, Crawford J, Grierson J, Kippax S. Marijuana as therapy for people living with HIV/AIDS: social and health aspects. AIDS Care. 2007;19:295–301. doi: 10.1080/09540120600841930. PMID: 17364413
   PubMed Web of Science ®Google Scholar
• Galvan FH, Bing EG, Fleishman JA, et al. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV cost and services utilization study. J Stud Alcohol. 2002;63:179–186. PMID: 12033694
   PubMed Web of Science ®Google Scholar
• Cardenas V, Meyerhoff D, Studholme C, et al. Evidence for ongoing brain injury in human immunodeficiency virus–positive patients treated with antiretroviral therapy. J Neurovirol. 2009;15:324–333. doi: 10.1080/13550280902973960.. PMID: 19499454
   PubMed Web of Science ®Google Scholar
• McArthur JC, Steiner J, Sacktor N, Nath A. Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann Neurol. 2010;67:699–714. doi: 10.1002/ana.22053. PMID: 20517932
   PubMed Web of Science ®Google Scholar
• Ances BM, Ellis RJ. Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol. 2007;27:086–092. doi: 10.1055/s-2006-956759.
   PubMed Web of Science ®Google Scholar
• Gannon P, Khan MZ, Kolson DL. Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol. 2011;24:275–283. doi: 10.1097/WCO.0b013e32834695fb. PMID: 21467932
   PubMed Web of Science ®Google Scholar
• Letendre S. Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder. Top Antivir Med. 2011;19:137–142. PMID: 22156215
   PubMedGoogle Scholar
• Simioni S, Cavassini M, Annoni J-M, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS. 2010;24:1243–1250. doi: 10.1097/QAD.0b013e3283354a7b.
   PubMed Web of Science ®Google Scholar
• Woods SP, Moore DJ, Weber E, Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev. 2009;19:152–168. doi: 10.1007/s11065-009-9102-5. PMID: 19462243
   PubMed Web of Science ®Google Scholar
• Bhatia NS, Chow FC. Neurologic complications in treated HIV-1 infection. Curr Neurol Neurosci Rep. 2016;16:62. doi: 10.1007/s11910-016-0666-1. PMID: 27170369
   PubMed Web of Science ®Google Scholar
• Ferretti F, Gisslen M, Cinque P, Price RW. Cerebrospinal fluid HIV escape from antiretroviral therapy. Curr HIV/AIDS Rep. 2015;12:280–288. doi: 10.1007/s11904-015-0267-7. PMID: 25860317
   PubMed Web of Science ®Google Scholar
• Price R, Bartlett J, Bloom A. HIV-associated neurocognitive disorders: epidemiology, clinical manifestations, and diagnosis. UpToDate Web site https://www.uptodate.com/contents/hiv-associated-neurocognitive-disorders-epidemiology-clinical-manifestations-and-diagnosis?source=search_result&search=HIV-associated%20neurocognitive%20disorders&selectedTitle=2∼22. Published 2015. Accessed June 28, 2016.
   Google Scholar
• Gonzalez R. Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance. Neuropsychol Rev. 2007;17:347–361. doi: 10.1007/s11065-007-9036-8. PMID: 17680367
   PubMed Web of Science ®Google Scholar
• Lundqvist T. Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacol Biochem Behav. 2005;81:319–330. doi: 10.1016/j.pbb.2005.02.017. PMID: 15925403
   PubMed Web of Science ®Google Scholar
• Block RI, O'Leary DS, Hichwa RD, et al. Effects of frequent marijuana use on memory-related regional cerebral blood flow. Pharmacol Biochem Behav. 2002;72:237–250. doi: 10.1016/S0091-3057(01)00771-7. PMID: 11900794
   PubMed Web of Science ®Google Scholar
• Kanayama G, Rogowska J, Pope HG, Gruber SA, Yurgelun-Todd DA. Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study. Psychopharmacology (Berl). 2004;176:239–247. doi: 10.1007/s00213-004-1885-8. PMID: 15205869
   PubMed Web of Science ®Google Scholar
• Jager G, Kahn RS, Van Den Brink W, Van Ree JM, Ramsey NF. Long-term effects of frequent cannabis use on working memory and attention: an fMRI study. Psychopharmacology (Berl). 2006;185:358–368. doi: 10.1007/s00213-005-0298-7. PMID: 16521034
   PubMed Web of Science ®Google Scholar
• Pope HG, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry. 2001;58:909–915. doi: 10.1001/archpsyc.58.10.909. PMID: 11576028
   PubMed Web of Science ®Google Scholar
• Cristiani SA, Pukay-Martin ND, Bornstein RA. Marijuana use and cognitive function in HIV-infected people. J Neuropsychiatry Clin Neurosci. 2004;16:330–335. doi: 10.1176/jnp.16.3.330. PMID: 15377740
   PubMed Web of Science ®Google Scholar
• Moselhy HF, Georgiou G, Kahn A. Frontal lobe changes in alcoholism: a review of the literature. Alcohol Alcohol. 2001;36:357–368. doi: 10.1093/alcalc/36.5.357.
   PubMed Web of Science ®Google Scholar
• Zhao Y-N, Wang F, Fan Y-X, Ping G-F, Yang J-Y, Wu C-F. Activated microglia are implicated in cognitive deficits, neuronal death, and successful recovery following intermittent ethanol exposure. Behav Brain Res. 2013;236:270–282. doi: 10.1016/j.bbr.2012.08.052. PMID: 22985845
   PubMed Web of Science ®Google Scholar
• Parsons OA. Neurocognitive deficits in alcoholics and social drinkers: a continuum? Alcohol Clin Exp Res. 1998;22:954–961. doi: 10.1111/j.1530-0277.1998.tb03895.x. PMID: 9660328
   PubMed Web of Science ®Google Scholar
• Ridley NJ, Draper B, Withall A. Alcohol-related dementia: an update of the evidence. Alzheimers Res Ther. 2013;5:3. doi: 10.1186/alzrt157. PMID: 23347747
   PubMed Web of Science ®Google Scholar
• Rothlind JC, Greenfield TM, Bruce AV, et al. Heavy alcohol consumption in individuals with HIV infection: effects on neuropsychological performance. J Int Neuropsychol Soc. 2005;11:70–83. doi: 10.1017/S1355617705050095.
   PubMed Web of Science ®Google Scholar
• Selnes O. Impact of HIV infection and alcohol on cognition: a review. Neurobehav HIV Med. 2010;2:85–94. doi: 10.2147/NBHIV.S736410.2147/NBHIV.S7364.
   Google Scholar
• Heaton RK, Marcotte TD, Mindt MR, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004;10:317–331. doi: 10.1017/S1355617704102130. PMID: 15147590
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Publishing; 1994.
   Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33. PMID: 9881538
   PubMed Web of Science ®Google Scholar
• Skinner HA, Sheu WJ. Reliability of alcohol use indices: the Lifetime Drinking History and the MAST. J Stud Alcohol. 1982;43(11):1157–1170. doi: 10.15288/jsa.1982.43.1157. PMID: 7182675
   PubMed Web of Science ®Google Scholar
• McLellan AT, Cacciola JC, Alterman AI, Rikoon SH, Carise C. The Addiction Severity Index at 25: origins, contributions and transitions. Am J Addict. 2006;15:113–124. doi: 10.1080/10550490500528316. PMID: 16595348
   PubMed Web of Science ®Google Scholar
• Sobell LC, Sobell MB. Timeline follow-back. In: Litten RZ, Allen JP, eds. Measuring Alcohol Consumption. Totowa, NJ: Humana Press; 1992:41–72. http://link.springer.com/chapter/10.1007/978-1-4612-0357-5_3. Accessed March 10, 2017.
   Google Scholar
• Kroenke K, Spitzer RL, Williams JBW. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41:1284–1292. doi: 10.1097/01.MLR.0000093487.78664.3C. PMID: 14583691
   PubMed Web of Science ®Google Scholar
• Norman SB, Hami Cissell S, Means-Christensen AJ, Stein MB. Development and validation of an Overall Anxiety Severity and Impairment Scale (OASIS). Depress Anxiety. 2006;23:245–249. doi: 10.1002/da.20182. PMID: 16688739
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383. PMID: 3558716
   PubMedGoogle Scholar
• Hasbun R, Eraso J, Ramireddy S, et al. Screening for neurocognitive impairment in HIV individuals: the utility of the Montreal Cognitive Assessment Test. J AIDS Clin Res. 2012;3:186. doi: 10.4172/2155-6113.1000186. PMID: 23956944
   PubMedGoogle Scholar
• Lam B, Middleton LE, Masellis M, et al. Criterion and convergent validity of the Montreal Cognitive Assessment with screening and standardized neuropsychological testing. J Am Geriatr Soc. 2013;61:2181–2185. doi: 10.1111/jgs.12541. PMID: 24320735
   PubMed Web of Science ®Google Scholar
• Wu AW, Revicki DA, Jacobson D, Malitz FE. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res. 1997;6:481–493. doi: 10.1023/A:1018451930750 10.1023/A:1018451930750.
   PubMed Web of Science ®Google Scholar
• Ramaekers JG, Kauert G, van Ruitenbeek P, Theunissen EL, Schneider E, Moeller MR. High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology. 2006;31:2296–2303. doi: 10.1038/sj.npp.1301068.
   PubMed Web of Science ®Google Scholar
• Schreiner AM, Dunn ME. Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: a meta-analysis. Exp Clin Psychopharmacol. 2012;20:420–429. doi: 10.1037/a0029117. PMID: 22731735
   PubMed Web of Science ®Google Scholar
• Auer R, Vittinghoff E, Yaffe K, et al. Association between lifetime marijuana use and cognitive function in middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) study. JAMA Intern Med. 2016;176:352–361. doi: 10.1001/jamainternmed.2015.7841. PMID: 26831916
   PubMed Web of Science ®Google Scholar
• Kennedy CA, Zerbo E. HIV-related neurocognitive disorders and drugs of abuse: mired in confound, surrounded by risk. Curr Addict Rep. 2014;1:229–236. doi: 10.1007/s40429-014-0028-5.
   Google Scholar
• Ranganathan M, D'Souza DC. The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology (Berl). 2006;188:425–444. doi: 10.1007/s00213-006-0508-y. PMID: 17019571
   PubMed Web of Science ®Google Scholar
• Crean RD, Crane NA, Mason BJ. An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med. 2011;5:1–8. doi: 10.1097/ADM.0b013e31820c23fa. PMID: 21321675
   PubMed Web of Science ®Google Scholar
• Parsons OA, Nixon SJ. Cognitive functioning in sober social drinkers: a review of the research since 1986. J Stud Alcohol. 1998;59:180–190. doi: 10.15288/jsa.1998.59.180.
   Google Scholar
• Kalapatapu RK, Ventura MI, Barnes DE. Lifetime alcohol use and cognitive performance in older adults. J Addict Dis. 2017;36:38–47. doi: 10.1080/10550887.2016.1245029. PMID: 27719514
   PubMed Web of Science ®Google Scholar
• He J, Crews FT. Increased MCP-1 and microglia in various regions of the human alcoholic brain. Exp Neurol. 2008;210:349–358. doi: 10.1016/j.expneurol.2007.11.017. PMID: 18190912
   PubMed Web of Science ®Google Scholar
• Bell JE, Arango J-C, Anthony IC. Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs. J Neuroimmune Pharmacol. 2006;1:182–191. doi: 10.1007/s11481-006-9018-2.
   PubMed Web of Science ®Google Scholar
• Martin-Thormeyer EM, Paul RH. Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging features. Neuropsychol Rev. 2009;19:215. doi: 10.1007/s11065-009-9101-6. PMID: 19468837
   PubMed Web of Science ®Google Scholar
• Monaco S, Mariotto S, Ferrari S, et al. Hepatitis C virus-associated neurocognitive and neuropsychiatric disorder: advances in 2015. World J Gastroenterol. 2015;21:11974–11983. doi: 10.3748/wig.v21.i42.11974. PMID: 26576086
   PubMed Web of Science ®Google Scholar